Cargando…

Targeted Sequencing Analysis of Matched Cell-Free DNA and White Blood Cells: A Facile Method for Detection of Residual Disease in Gastric Cancer

Detalles Bibliográficos
Autor principal:	Diao, Feiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490118/ https://www.ncbi.nlm.nih.gov/pubmed/32939511 http://dx.doi.org/10.1055/s-0040-1716333

Ejemplares similares

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
por: Leal, Alessandro, et al.
Publicado: (2020)

The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction
por: van der Leest, Paul, et al.
Publicado: (2020)

Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells
por: van 't Erve, Iris, et al.
Publicado: (2023)

Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance
por: Siravegna, Giulia, et al.
Publicado: (2014)

Bisulfite Amplicon Sequencing Can Detect Glia and Neuron Cell-Free DNA in Blood Plasma
por: Chatterton, Zac, et al.
Publicado: (2021)

Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer
por: Yang, Jian, et al.
Publicado: (2020)

Detection of fusion gene in cell-free DNA of a gastric synovial sarcoma
por: Ogino, Shinpei, et al.
Publicado: (2018)

Cell-free DNA as a liquid biopsy for early detection of gastric cancer
por: Huang, Zheng-Bin, et al.
Publicado: (2021)

An Improved Computer Vision Method for White Blood Cells Detection
por: Cuevas, Erik, et al.
Publicado: (2013)

Cell-free RB1 DNA not detected in the blood of pseudoretinoblastoma patients
por: Abramson, David H, et al.
Publicado: (2022)

Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics
por: Wang, Siwei, et al.
Publicado: (2023)

Cancer detection using whole-genome sequencing of cell free DNA
por: Leary, Rebecca J., et al.
Publicado: (2013)

Single-Cell Landscape of Liver Cancer in Response to Immunotherapy
por: Diao, Feiyu
Publicado: (2021)

Low lymphocyte-to-white blood cell ratio and high monocyte-to-white blood cell ratio predict poor prognosis in gastric cancer
por: Feng, Fan, et al.
Publicado: (2016)

The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC
por: Yang, Yang, et al.
Publicado: (2017)

Label‐Free Identification of White Blood Cells Using Machine Learning
por: Nassar, Mariam, et al.
Publicado: (2019)

Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection
por: Pantel, Klaus
Publicado: (2016)

S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer
por: Diao, Feiyu, et al.
Publicado: (2019)

Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
por: Chen, Xiaoji, et al.
Publicado: (2021)

Quantification of Cell-Free DNA in Red Blood Cell Units in Different Whole Blood Processing Methods
por: Shih, Andrew W., et al.
Publicado: (2016)

Detection of mutational patterns in cell‐free DNA of colorectal cancer by custom amplicon sequencing
por: Herrmann, Simon, et al.
Publicado: (2019)

Targeted Sequencing of Genomic Repeat Regions Detects Circulating Cell-free Echinococcus DNA
por: Wan, Zhengqing, et al.
Publicado: (2020)

Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer
por: Stackpole, Mary L., et al.
Publicado: (2022)

Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization
por: Bie, Fenglong, et al.
Publicado: (2023)

Multi-faceted attributes of salivary cell-free DNA as liquid biopsy biomarkers for gastric cancer detection
por: Swarup, Neeti, et al.
Publicado: (2023)

Multi-Faceted Attributes of Salivary Cell-free DNA as Liquid Biopsy Biomarkers for Gastric Cancer Detection
por: Swarup, Neeti, et al.
Publicado: (2023)

Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
por: Katsman, Efrat, et al.
Publicado: (2022)

Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer
por: Yu, Pengjie, et al.
Publicado: (2022)

INSIDER: alignment-free detection of foreign DNA sequences
por: Tay, Aidan P., et al.
Publicado: (2021)

Oxaliplatin-DNA adduct formation in white blood cells of cancer patients
por: Pieck, A C, et al.
Publicado: (2008)

Promoter Hypermethylation in White Blood Cell DNA and Breast Cancer Risk
por: Cho, Yoon Hee, et al.
Publicado: (2015)

Facile Label-Free Electrochemical DNA Biosensor for Detection of Osteosarcoma-Related Survivin Gene
por: Chen, Yao, et al.
Publicado: (2022)

Multidimensional Analysis of a Cell-Free DNA Whole Methylome Sequencing Assay for Early Detection of Gastric Cancer: Protocol for an Observational Case-Control Study
por: Han, Yongjun, et al.
Publicado: (2023)

A Digestion-free Method for Quantification of Residual Host Cell DNA in rAAV Gene Therapy Products
por: Wang, Yu, et al.
Publicado: (2019)

Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes
por: Pasca, Sergiu, et al.
Publicado: (2023)

Gastric fluid cytokines are associated with chorioamnionitis and white blood cell counts in preterm infants
por: Bry, K J K, et al.
Publicado: (2015)

Cell free DNA from respiratory pathogens is detectable in the blood plasma of Cystic Fibrosis patients
por: Barrett, Sara L. Rassoulian, et al.
Publicado: (2020)

Dual-molecular barcode sequencing detects rare variants in tumor and cell free DNA in plasma
por: Hirotsu, Yosuke, et al.
Publicado: (2020)

Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNA
por: Guo, Ping, et al.
Publicado: (2023)

Deep sequencing in CD34(+) cells from peripheral blood enables sensitive detection of measurable residual disease in AML
por: Stasik, Sebastian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_64l27r6caoimueut8uso51gbhj